139 related articles for article (PubMed ID: 15481631)
1. Platelet activation in heart failure.
Schäfer A; Eigenthaler M; Bauersachs J
Clin Lab; 2004; 50(9-10):559-66. PubMed ID: 15481631
[TBL] [Abstract][Full Text] [Related]
2. Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system.
Bauersachs J; Schäfer A
Arch Mal Coeur Vaiss; 2004 Sep; 97(9):889-93. PubMed ID: 15521482
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer.
Schäfer A; Fraccarollo D; Widder J; Eigenthaler M; Ertl G; Bauersachs J
Eur J Heart Fail; 2009 Apr; 11(4):336-41. PubMed ID: 19193626
[TBL] [Abstract][Full Text] [Related]
4. Platelets and heart failure.
Chung I; Lip GY
Eur Heart J; 2006 Nov; 27(22):2623-31. PubMed ID: 17028108
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
[TBL] [Abstract][Full Text] [Related]
6. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.
Akar JG; Jeske W; Wilber DJ
J Am Coll Cardiol; 2008 May; 51(18):1790-3. PubMed ID: 18452786
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
8. The direct factor Xa inhibitor Rivaroxaban reduces platelet activation in congestive heart failure.
Flierl U; Fraccarollo D; Micka J; Bauersachs J; Schäfer A
Pharmacol Res; 2013 Aug; 74():49-55. PubMed ID: 23714416
[TBL] [Abstract][Full Text] [Related]
9. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation in acute, decompensated congestive heart failure.
Chung I; Choudhury A; Lip GY
Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
[TBL] [Abstract][Full Text] [Related]
11. Enhanced platelet activation by prolactin in patients with ischemic stroke.
Wallaschofski H; Lohmann T; Hild E; Kobsar A; Siegemund A; Spilcke-Liss E; Hentschel B; Stumpf C; Daniel WG; Garlichs CD; Eigenthaler M
Thromb Haemost; 2006 Jul; 96(1):38-44. PubMed ID: 16807649
[TBL] [Abstract][Full Text] [Related]
12. Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease.
Robinson SD; Harding SA; Cummins P; Din JN; Sarma J; Davidson I; Fox KA; Boon NA; Newby DE
Platelets; 2006 May; 17(3):158-62. PubMed ID: 16702042
[TBL] [Abstract][Full Text] [Related]
13. Hypercoagulability in heart failure.
Jafri SM
Semin Thromb Hemost; 1997; 23(6):543-5. PubMed ID: 9469627
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
Tousoulis D; Charakida M; Stefanadis C
Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
[TBL] [Abstract][Full Text] [Related]
15. Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Stumpf C; Lehner C; Raaz D; Yilmaz A; Anger T; Daniel WG; Garlichs CD
Heart; 2008 Jan; 94(1):65-9. PubMed ID: 17575327
[TBL] [Abstract][Full Text] [Related]
16. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activation.
Bauersachs J
Eur J Clin Invest; 2004 Oct; 34(10):649-52. PubMed ID: 15473888
[No Abstract] [Full Text] [Related]
18. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
19. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Pihusch V; Pihusch M; Penovici M; Kolb HJ; Hiller E; Pihusch R
Thromb Res; 2005; 116(3):233-40. PubMed ID: 15935832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
